Why the study?
To investigate dynamic lipid profile changes under double filtration plasmapheresis in severe hypertriglyceridemia-induced acute pancreatitis patients and determine their association with clinical prognosis.
Does double filtration plasmapheresis improve lipid profiles and clinical prognosis in patients with severe hypertriglyceridemia-induced acute pancreatitis?
Does double filtration plasmapheresis improve lipid profiles and clinical prognosis in patients with severe hypertriglyceridemia-induced acute pancreatitis?
Double filtration plasmapheresis significantly improves lipid profiles in severe hypertriglyceridemia-induced acute pancreatitis, with HDL levels negatively correlating with hospitalization duration.
DFPP was associated with improved lipids and shorter stays in HTG-AP; hypothesis-generating, RCTs needed before practice change.
Background: To investigate the dynamic change of lipid profile under double filtration plasmapheresis (DFPP) in severe hypertriglyceridemia-induced acute pancreatitis (sHTGP) patients and ascertain the association between these changes and the clinical prognosis. Methods: sHTGP patients admitted within 72h after disease onset were included, and all the patients received DFPP within 24h after admission. Lipid profile were detected on admission, consecutive 4 days after DFPP and at discharge. Results: There were 47 sHTGP patients enrolled in this study. At admission, all the parameters of lipid profile changed significantly except for low density lipoprotein. In the first day after DFPP, the serum level of TG, cholesterol and very low density lipoprotein declined significantly, while the high-density lipoprotein (HDL) as well as apoprotein A1 elevated obviously ( P < 0.05). TG maintained the downward trend in the following three days and the other parameters kept steady. Linear regression analysis showed that HDL was negatively correlated with the duration of hospitalization among three adjusted models ( P = 0.043, P = 0.029, P =0.025 respectively). Conclusion: There was distinct fluctuation of the lipid profile upon the burst of sHTGP and the parameters changed significantly in the first day after DFPP. Among these parameters, HDL may serve as a biomarker for disease prognosis in patients with sHTGP.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: